These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 23642060)

  • 1. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
    Easley CA
    Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comment on pluripotent stem cells in next-generation biomedical theranostics.
    Rossbach M
    Curr Mol Med; 2013 Jun; 13(5):879-83. PubMed ID: 23642068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
    Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
    J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
    Walia B; Satija N; Tripathi RP; Gangenahalli GU
    Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present and future challenges of induced pluripotent stem cells.
    Ohnuki M; Takahashi K
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
    Lin L; Bolund L; Luo Y
    Curr Stem Cell Res Ther; 2016; 11(2):122-30. PubMed ID: 26201862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Regenerative Medicine.
    Arjmand B; Goodarzi P; Mohamadi-Jahani F; Falahzadeh K; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):144-149. PubMed ID: 28282715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Human-induced Pluripotent Stem Cell the Best Optimal?
    Wang F; Kong J; Cui YY; Liu P; Wen JY
    Chin Med J (Engl); 2018 Apr; 131(7):852-856. PubMed ID: 29578130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.
    Sayed N; Liu C; Wu JC
    J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPSC technology-based regenerative therapy for diabetes.
    Kondo Y; Toyoda T; Inagaki N; Osafune K
    J Diabetes Investig; 2018 Mar; 9(2):234-243. PubMed ID: 28609558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
    Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
    Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will SCNT-ESCs be better than iPSCs for personalized regenerative medicine?
    Sancho-Martinez I; Izpisua Belmonte JC
    Cell Stem Cell; 2013 Aug; 13(2):141-2. PubMed ID: 23910080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.